nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP2D6—Alzheimer's disease	0.339	1	CbGaD
Darifenacin—CYP2D6—Rivastigmine—Alzheimer's disease	0.109	0.264	CbGbCtD
Darifenacin—CYP2D6—Donepezil—Alzheimer's disease	0.0871	0.211	CbGbCtD
Darifenacin—CYP3A4—Rivastigmine—Alzheimer's disease	0.0693	0.168	CbGbCtD
Darifenacin—CYP2D6—Galantamine—Alzheimer's disease	0.0561	0.136	CbGbCtD
Darifenacin—CYP3A4—Donepezil—Alzheimer's disease	0.0554	0.134	CbGbCtD
Darifenacin—CYP3A4—Galantamine—Alzheimer's disease	0.0357	0.0865	CbGbCtD
Darifenacin—Vaginal inflammation—Rivastigmine—Alzheimer's disease	0.00136	0.00733	CcSEcCtD
Darifenacin—Abnormal vision—Donepezil—Alzheimer's disease	0.00134	0.00719	CcSEcCtD
Darifenacin—Vaginal infection—Rivastigmine—Alzheimer's disease	0.00129	0.00692	CcSEcCtD
Darifenacin—Bladder pain—Memantine—Alzheimer's disease	0.00126	0.00677	CcSEcCtD
Darifenacin—Mouth ulceration—Memantine—Alzheimer's disease	0.00126	0.00677	CcSEcCtD
Darifenacin—Bladder pain—Rivastigmine—Alzheimer's disease	0.00123	0.00662	CcSEcCtD
Darifenacin—Mouth ulceration—Rivastigmine—Alzheimer's disease	0.00123	0.00662	CcSEcCtD
Darifenacin—Abnormal vision—Memantine—Alzheimer's disease	0.00121	0.00653	CcSEcCtD
Darifenacin—Injury—Donepezil—Alzheimer's disease	0.00121	0.00651	CcSEcCtD
Darifenacin—Mental disability—Memantine—Alzheimer's disease	0.00121	0.0065	CcSEcCtD
Darifenacin—Bronchitis—Galantamine—Alzheimer's disease	0.00119	0.00642	CcSEcCtD
Darifenacin—Abnormal vision—Rivastigmine—Alzheimer's disease	0.00119	0.00639	CcSEcCtD
Darifenacin—Mental disability—Rivastigmine—Alzheimer's disease	0.00118	0.00636	CcSEcCtD
Darifenacin—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.00114	0.00611	CcSEcCtD
Darifenacin—Injury—Memantine—Alzheimer's disease	0.0011	0.00591	CcSEcCtD
Darifenacin—Urinary tract infection—Galantamine—Alzheimer's disease	0.00108	0.00579	CcSEcCtD
Darifenacin—Injury—Rivastigmine—Alzheimer's disease	0.00108	0.00579	CcSEcCtD
Darifenacin—Face oedema—Donepezil—Alzheimer's disease	0.00108	0.00578	CcSEcCtD
Darifenacin—Urinary retention—Donepezil—Alzheimer's disease	0.00106	0.00569	CcSEcCtD
Darifenacin—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00103	0.00555	CcSEcCtD
Darifenacin—Dry skin—Donepezil—Alzheimer's disease	0.00102	0.00549	CcSEcCtD
Darifenacin—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.00101	0.00543	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.001	0.00539	CcSEcCtD
Darifenacin—Rhinitis—Galantamine—Alzheimer's disease	0.000997	0.00536	CcSEcCtD
Darifenacin—CHRM4—nervous system—Alzheimer's disease	0.000995	0.0618	CbGeAlD
Darifenacin—Hallucination—Galantamine—Alzheimer's disease	0.000989	0.00532	CcSEcCtD
Darifenacin—CHRM2—forebrain—Alzheimer's disease	0.000984	0.061	CbGeAlD
Darifenacin—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000982	0.00528	CcSEcCtD
Darifenacin—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000982	0.00528	CcSEcCtD
Darifenacin—Oedema peripheral—Galantamine—Alzheimer's disease	0.000979	0.00526	CcSEcCtD
Darifenacin—Urethral disorder—Galantamine—Alzheimer's disease	0.000975	0.00524	CcSEcCtD
Darifenacin—Influenza—Donepezil—Alzheimer's disease	0.000963	0.00517	CcSEcCtD
Darifenacin—Urinary retention—Memantine—Alzheimer's disease	0.000962	0.00517	CcSEcCtD
Darifenacin—CHRM4—central nervous system—Alzheimer's disease	0.000958	0.0595	CbGeAlD
Darifenacin—Visual impairment—Galantamine—Alzheimer's disease	0.000958	0.00515	CcSEcCtD
Darifenacin—Face oedema—Rivastigmine—Alzheimer's disease	0.000955	0.00513	CcSEcCtD
Darifenacin—Urinary retention—Rivastigmine—Alzheimer's disease	0.000941	0.00506	CcSEcCtD
Darifenacin—Eye disorder—Galantamine—Alzheimer's disease	0.000929	0.00499	CcSEcCtD
Darifenacin—Dry skin—Memantine—Alzheimer's disease	0.000927	0.00498	CcSEcCtD
Darifenacin—Bronchitis—Donepezil—Alzheimer's disease	0.000926	0.00498	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000911	0.00489	CcSEcCtD
Darifenacin—Dry skin—Rivastigmine—Alzheimer's disease	0.000907	0.00487	CcSEcCtD
Darifenacin—CHRM2—telencephalon—Alzheimer's disease	0.000905	0.0561	CbGeAlD
Darifenacin—Angiopathy—Galantamine—Alzheimer's disease	0.000902	0.00485	CcSEcCtD
Darifenacin—CHRM1—forebrain—Alzheimer's disease	0.000896	0.0556	CbGeAlD
Darifenacin—Breast disorder—Rivastigmine—Alzheimer's disease	0.000894	0.00481	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000892	0.00479	CcSEcCtD
Darifenacin—Weight increased—Donepezil—Alzheimer's disease	0.000876	0.00471	CcSEcCtD
Darifenacin—Influenza—Memantine—Alzheimer's disease	0.000874	0.0047	CcSEcCtD
Darifenacin—Mental disorder—Galantamine—Alzheimer's disease	0.000871	0.00468	CcSEcCtD
Darifenacin—Infestation NOS—Donepezil—Alzheimer's disease	0.000858	0.00461	CcSEcCtD
Darifenacin—Infestation—Donepezil—Alzheimer's disease	0.000858	0.00461	CcSEcCtD
Darifenacin—Flatulence—Galantamine—Alzheimer's disease	0.000853	0.00458	CcSEcCtD
Darifenacin—Dysgeusia—Galantamine—Alzheimer's disease	0.000848	0.00456	CcSEcCtD
Darifenacin—Bronchitis—Memantine—Alzheimer's disease	0.000841	0.00452	CcSEcCtD
Darifenacin—Back pain—Galantamine—Alzheimer's disease	0.000837	0.0045	CcSEcCtD
Darifenacin—Urinary tract infection—Donepezil—Alzheimer's disease	0.000834	0.00448	CcSEcCtD
Darifenacin—CHRM1—telencephalon—Alzheimer's disease	0.000823	0.0511	CbGeAlD
Darifenacin—Sweating—Donepezil—Alzheimer's disease	0.000823	0.00442	CcSEcCtD
Darifenacin—Bronchitis—Rivastigmine—Alzheimer's disease	0.000822	0.00442	CcSEcCtD
Darifenacin—Vision blurred—Galantamine—Alzheimer's disease	0.000816	0.00438	CcSEcCtD
Darifenacin—Erectile dysfunction—Memantine—Alzheimer's disease	0.000805	0.00433	CcSEcCtD
Darifenacin—CHRM3—forebrain—Alzheimer's disease	0.000801	0.0497	CbGeAlD
Darifenacin—Weight increased—Memantine—Alzheimer's disease	0.000795	0.00428	CcSEcCtD
Darifenacin—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000787	0.00423	CcSEcCtD
Darifenacin—Loperamide—CALM1—Alzheimer's disease	0.00078	0.38	CrCbGaD
Darifenacin—Infestation NOS—Memantine—Alzheimer's disease	0.000779	0.00419	CcSEcCtD
Darifenacin—Infestation—Memantine—Alzheimer's disease	0.000779	0.00419	CcSEcCtD
Darifenacin—Weight increased—Rivastigmine—Alzheimer's disease	0.000778	0.00418	CcSEcCtD
Darifenacin—CHRM5—nervous system—Alzheimer's disease	0.000778	0.0483	CbGeAlD
Darifenacin—Syncope—Galantamine—Alzheimer's disease	0.000776	0.00417	CcSEcCtD
Darifenacin—Rhinitis—Donepezil—Alzheimer's disease	0.000772	0.00415	CcSEcCtD
Darifenacin—Hallucination—Donepezil—Alzheimer's disease	0.000767	0.00412	CcSEcCtD
Darifenacin—Palpitations—Galantamine—Alzheimer's disease	0.000765	0.00411	CcSEcCtD
Darifenacin—Pharyngitis—Donepezil—Alzheimer's disease	0.000765	0.00411	CcSEcCtD
Darifenacin—Infestation—Rivastigmine—Alzheimer's disease	0.000762	0.0041	CcSEcCtD
Darifenacin—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000762	0.0041	CcSEcCtD
Darifenacin—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000761	0.00409	CcSEcCtD
Darifenacin—CHRM4—brain—Alzheimer's disease	0.000761	0.0472	CbGeAlD
Darifenacin—Loss of consciousness—Galantamine—Alzheimer's disease	0.000761	0.00409	CcSEcCtD
Darifenacin—Oedema peripheral—Donepezil—Alzheimer's disease	0.000759	0.00408	CcSEcCtD
Darifenacin—Urinary tract infection—Memantine—Alzheimer's disease	0.000757	0.00407	CcSEcCtD
Darifenacin—Urethral disorder—Donepezil—Alzheimer's disease	0.000755	0.00406	CcSEcCtD
Darifenacin—Cough—Galantamine—Alzheimer's disease	0.000755	0.00406	CcSEcCtD
Darifenacin—CHRM5—central nervous system—Alzheimer's disease	0.000749	0.0465	CbGeAlD
Darifenacin—Hypertension—Galantamine—Alzheimer's disease	0.000747	0.00402	CcSEcCtD
Darifenacin—Visual impairment—Donepezil—Alzheimer's disease	0.000743	0.00399	CcSEcCtD
Darifenacin—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000741	0.00398	CcSEcCtD
Darifenacin—CHRM3—telencephalon—Alzheimer's disease	0.000737	0.0457	CbGeAlD
Darifenacin—Arthralgia—Galantamine—Alzheimer's disease	0.000737	0.00396	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000732	0.00393	CcSEcCtD
Darifenacin—Sinusitis—Memantine—Alzheimer's disease	0.000731	0.00393	CcSEcCtD
Darifenacin—Sweating—Rivastigmine—Alzheimer's disease	0.000731	0.00393	CcSEcCtD
Darifenacin—Dry mouth—Galantamine—Alzheimer's disease	0.000721	0.00387	CcSEcCtD
Darifenacin—Sinusitis—Rivastigmine—Alzheimer's disease	0.000715	0.00384	CcSEcCtD
Darifenacin—Confusional state—Galantamine—Alzheimer's disease	0.000712	0.00383	CcSEcCtD
Darifenacin—Rhinitis—Memantine—Alzheimer's disease	0.000701	0.00377	CcSEcCtD
Darifenacin—Hallucination—Memantine—Alzheimer's disease	0.000696	0.00374	CcSEcCtD
Darifenacin—Shock—Galantamine—Alzheimer's disease	0.000695	0.00374	CcSEcCtD
Darifenacin—Pharyngitis—Memantine—Alzheimer's disease	0.000694	0.00373	CcSEcCtD
Darifenacin—Nervous system disorder—Galantamine—Alzheimer's disease	0.000693	0.00372	CcSEcCtD
Darifenacin—Urinary tract disorder—Memantine—Alzheimer's disease	0.000691	0.00371	CcSEcCtD
Darifenacin—Tachycardia—Galantamine—Alzheimer's disease	0.000689	0.00371	CcSEcCtD
Darifenacin—Oedema peripheral—Memantine—Alzheimer's disease	0.000689	0.0037	CcSEcCtD
Darifenacin—Rhinitis—Rivastigmine—Alzheimer's disease	0.000686	0.00369	CcSEcCtD
Darifenacin—Skin disorder—Galantamine—Alzheimer's disease	0.000686	0.00369	CcSEcCtD
Darifenacin—Urethral disorder—Memantine—Alzheimer's disease	0.000686	0.00369	CcSEcCtD
Darifenacin—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000683	0.00367	CcSEcCtD
Darifenacin—Hallucination—Rivastigmine—Alzheimer's disease	0.000681	0.00366	CcSEcCtD
Darifenacin—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000679	0.00365	CcSEcCtD
Darifenacin—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000676	0.00363	CcSEcCtD
Darifenacin—Mental disorder—Donepezil—Alzheimer's disease	0.000675	0.00363	CcSEcCtD
Darifenacin—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000674	0.00362	CcSEcCtD
Darifenacin—Visual impairment—Memantine—Alzheimer's disease	0.000674	0.00362	CcSEcCtD
Darifenacin—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000671	0.00361	CcSEcCtD
Darifenacin—Erythema multiforme—Memantine—Alzheimer's disease	0.000661	0.00356	CcSEcCtD
Darifenacin—Flatulence—Donepezil—Alzheimer's disease	0.000661	0.00355	CcSEcCtD
Darifenacin—Visual impairment—Rivastigmine—Alzheimer's disease	0.00066	0.00355	CcSEcCtD
Darifenacin—Dysgeusia—Donepezil—Alzheimer's disease	0.000657	0.00353	CcSEcCtD
Darifenacin—Eye disorder—Memantine—Alzheimer's disease	0.000654	0.00351	CcSEcCtD
Darifenacin—Back pain—Donepezil—Alzheimer's disease	0.000649	0.00349	CcSEcCtD
Darifenacin—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000647	0.00348	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000644	0.00346	CcSEcCtD
Darifenacin—Eye disorder—Rivastigmine—Alzheimer's disease	0.00064	0.00344	CcSEcCtD
Darifenacin—Insomnia—Galantamine—Alzheimer's disease	0.000639	0.00343	CcSEcCtD
Darifenacin—Angiopathy—Memantine—Alzheimer's disease	0.000635	0.00341	CcSEcCtD
Darifenacin—Vision blurred—Donepezil—Alzheimer's disease	0.000632	0.0034	CcSEcCtD
Darifenacin—Mediastinal disorder—Memantine—Alzheimer's disease	0.00063	0.00339	CcSEcCtD
Darifenacin—Somnolence—Galantamine—Alzheimer's disease	0.000628	0.00338	CcSEcCtD
Darifenacin—Dyspepsia—Galantamine—Alzheimer's disease	0.000622	0.00334	CcSEcCtD
Darifenacin—Angiopathy—Rivastigmine—Alzheimer's disease	0.000621	0.00334	CcSEcCtD
Darifenacin—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000617	0.00332	CcSEcCtD
Darifenacin—Mental disorder—Memantine—Alzheimer's disease	0.000613	0.00329	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00061	0.00328	CcSEcCtD
Darifenacin—Constipation—Galantamine—Alzheimer's disease	0.000604	0.00325	CcSEcCtD
Darifenacin—Syncope—Donepezil—Alzheimer's disease	0.000601	0.00323	CcSEcCtD
Darifenacin—Flatulence—Memantine—Alzheimer's disease	0.0006	0.00323	CcSEcCtD
Darifenacin—Mental disorder—Rivastigmine—Alzheimer's disease	0.0006	0.00322	CcSEcCtD
Darifenacin—Dysgeusia—Memantine—Alzheimer's disease	0.000596	0.00321	CcSEcCtD
Darifenacin—CHRM5—brain—Alzheimer's disease	0.000595	0.0369	CbGeAlD
Darifenacin—Loss of consciousness—Donepezil—Alzheimer's disease	0.00059	0.00317	CcSEcCtD
Darifenacin—Back pain—Memantine—Alzheimer's disease	0.000589	0.00317	CcSEcCtD
Darifenacin—Flatulence—Rivastigmine—Alzheimer's disease	0.000587	0.00316	CcSEcCtD
Darifenacin—Cough—Donepezil—Alzheimer's disease	0.000585	0.00315	CcSEcCtD
Darifenacin—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000583	0.00314	CcSEcCtD
Darifenacin—Feeling abnormal—Galantamine—Alzheimer's disease	0.000582	0.00313	CcSEcCtD
Darifenacin—Hypertension—Donepezil—Alzheimer's disease	0.000579	0.00311	CcSEcCtD
Darifenacin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000578	0.0031	CcSEcCtD
Darifenacin—Back pain—Rivastigmine—Alzheimer's disease	0.000576	0.0031	CcSEcCtD
Darifenacin—Vision blurred—Memantine—Alzheimer's disease	0.000574	0.00309	CcSEcCtD
Darifenacin—Arthralgia—Donepezil—Alzheimer's disease	0.000571	0.00307	CcSEcCtD
Darifenacin—Vision blurred—Rivastigmine—Alzheimer's disease	0.000561	0.00302	CcSEcCtD
Darifenacin—Dry mouth—Donepezil—Alzheimer's disease	0.000558	0.003	CcSEcCtD
Darifenacin—Abdominal pain—Galantamine—Alzheimer's disease	0.000558	0.003	CcSEcCtD
Darifenacin—Confusional state—Donepezil—Alzheimer's disease	0.000552	0.00297	CcSEcCtD
Darifenacin—Oedema—Donepezil—Alzheimer's disease	0.000547	0.00294	CcSEcCtD
Darifenacin—Syncope—Memantine—Alzheimer's disease	0.000546	0.00294	CcSEcCtD
Darifenacin—Infection—Donepezil—Alzheimer's disease	0.000544	0.00292	CcSEcCtD
Darifenacin—Shock—Donepezil—Alzheimer's disease	0.000539	0.00289	CcSEcCtD
Darifenacin—Palpitations—Memantine—Alzheimer's disease	0.000538	0.00289	CcSEcCtD
Darifenacin—Nervous system disorder—Donepezil—Alzheimer's disease	0.000537	0.00289	CcSEcCtD
Darifenacin—Loss of consciousness—Memantine—Alzheimer's disease	0.000535	0.00288	CcSEcCtD
Darifenacin—Syncope—Rivastigmine—Alzheimer's disease	0.000534	0.00287	CcSEcCtD
Darifenacin—CHRM2—nervous system—Alzheimer's disease	0.000534	0.0331	CbGeAlD
Darifenacin—Cough—Memantine—Alzheimer's disease	0.000531	0.00286	CcSEcCtD
Darifenacin—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000529	0.00284	CcSEcCtD
Darifenacin—Palpitations—Rivastigmine—Alzheimer's disease	0.000526	0.00283	CcSEcCtD
Darifenacin—Hypertension—Memantine—Alzheimer's disease	0.000526	0.00283	CcSEcCtD
Darifenacin—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000524	0.00281	CcSEcCtD
Darifenacin—Hypersensitivity—Galantamine—Alzheimer's disease	0.00052	0.0028	CcSEcCtD
Darifenacin—Cough—Rivastigmine—Alzheimer's disease	0.00052	0.00279	CcSEcCtD
Darifenacin—Arthralgia—Memantine—Alzheimer's disease	0.000518	0.00279	CcSEcCtD
Darifenacin—Hypertension—Rivastigmine—Alzheimer's disease	0.000514	0.00276	CcSEcCtD
Darifenacin—CHRM2—central nervous system—Alzheimer's disease	0.000514	0.0319	CbGeAlD
Darifenacin—Arthralgia—Rivastigmine—Alzheimer's disease	0.000507	0.00273	CcSEcCtD
Darifenacin—Dry mouth—Memantine—Alzheimer's disease	0.000507	0.00273	CcSEcCtD
Darifenacin—Asthenia—Galantamine—Alzheimer's disease	0.000507	0.00272	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000504	0.00271	CcSEcCtD
Darifenacin—Confusional state—Memantine—Alzheimer's disease	0.000501	0.00269	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000499	0.00268	CcSEcCtD
Darifenacin—Oedema—Memantine—Alzheimer's disease	0.000497	0.00267	CcSEcCtD
Darifenacin—Dry mouth—Rivastigmine—Alzheimer's disease	0.000496	0.00267	CcSEcCtD
Darifenacin—Insomnia—Donepezil—Alzheimer's disease	0.000495	0.00266	CcSEcCtD
Darifenacin—Infection—Memantine—Alzheimer's disease	0.000494	0.00265	CcSEcCtD
Darifenacin—Confusional state—Rivastigmine—Alzheimer's disease	0.00049	0.00264	CcSEcCtD
Darifenacin—Shock—Memantine—Alzheimer's disease	0.000489	0.00263	CcSEcCtD
Darifenacin—Dyspnoea—Donepezil—Alzheimer's disease	0.000488	0.00262	CcSEcCtD
Darifenacin—Nervous system disorder—Memantine—Alzheimer's disease	0.000487	0.00262	CcSEcCtD
Darifenacin—Somnolence—Donepezil—Alzheimer's disease	0.000487	0.00262	CcSEcCtD
Darifenacin—Oedema—Rivastigmine—Alzheimer's disease	0.000486	0.00261	CcSEcCtD
Darifenacin—CHRM1—nervous system—Alzheimer's disease	0.000486	0.0302	CbGeAlD
Darifenacin—Tachycardia—Memantine—Alzheimer's disease	0.000485	0.00261	CcSEcCtD
Darifenacin—Diarrhoea—Galantamine—Alzheimer's disease	0.000483	0.0026	CcSEcCtD
Darifenacin—Infection—Rivastigmine—Alzheimer's disease	0.000483	0.0026	CcSEcCtD
Darifenacin—Skin disorder—Memantine—Alzheimer's disease	0.000483	0.00259	CcSEcCtD
Darifenacin—Dyspepsia—Donepezil—Alzheimer's disease	0.000482	0.00259	CcSEcCtD
Darifenacin—Hyperhidrosis—Memantine—Alzheimer's disease	0.00048	0.00258	CcSEcCtD
Darifenacin—Shock—Rivastigmine—Alzheimer's disease	0.000478	0.00257	CcSEcCtD
Darifenacin—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000477	0.00256	CcSEcCtD
Darifenacin—Tachycardia—Rivastigmine—Alzheimer's disease	0.000475	0.00255	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000473	0.00254	CcSEcCtD
Darifenacin—Skin disorder—Rivastigmine—Alzheimer's disease	0.000472	0.00254	CcSEcCtD
Darifenacin—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00047	0.00253	CcSEcCtD
Darifenacin—Pain—Donepezil—Alzheimer's disease	0.000468	0.00252	CcSEcCtD
Darifenacin—Constipation—Donepezil—Alzheimer's disease	0.000468	0.00252	CcSEcCtD
Darifenacin—CHRM1—central nervous system—Alzheimer's disease	0.000468	0.029	CbGeAlD
Darifenacin—Dizziness—Galantamine—Alzheimer's disease	0.000467	0.00251	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000453	0.00243	CcSEcCtD
Darifenacin—Feeling abnormal—Donepezil—Alzheimer's disease	0.000451	0.00242	CcSEcCtD
Darifenacin—Insomnia—Memantine—Alzheimer's disease	0.00045	0.00242	CcSEcCtD
Darifenacin—Vomiting—Galantamine—Alzheimer's disease	0.000449	0.00241	CcSEcCtD
Darifenacin—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000448	0.00241	CcSEcCtD
Darifenacin—Rash—Galantamine—Alzheimer's disease	0.000445	0.00239	CcSEcCtD
Darifenacin—Dermatitis—Galantamine—Alzheimer's disease	0.000445	0.00239	CcSEcCtD
Darifenacin—Dyspnoea—Memantine—Alzheimer's disease	0.000443	0.00238	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000443	0.00238	CcSEcCtD
Darifenacin—Headache—Galantamine—Alzheimer's disease	0.000442	0.00238	CcSEcCtD
Darifenacin—Somnolence—Memantine—Alzheimer's disease	0.000442	0.00238	CcSEcCtD
Darifenacin—Insomnia—Rivastigmine—Alzheimer's disease	0.00044	0.00236	CcSEcCtD
Darifenacin—Dyspepsia—Memantine—Alzheimer's disease	0.000438	0.00235	CcSEcCtD
Darifenacin—CHRM3—nervous system—Alzheimer's disease	0.000435	0.027	CbGeAlD
Darifenacin—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000433	0.00233	CcSEcCtD
Darifenacin—CYP2D6—forebrain—Alzheimer's disease	0.000433	0.0269	CbGeAlD
Darifenacin—Abdominal pain—Donepezil—Alzheimer's disease	0.000433	0.00233	CcSEcCtD
Darifenacin—Somnolence—Rivastigmine—Alzheimer's disease	0.000432	0.00232	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000429	0.00231	CcSEcCtD
Darifenacin—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000428	0.0023	CcSEcCtD
Darifenacin—Constipation—Memantine—Alzheimer's disease	0.000425	0.00228	CcSEcCtD
Darifenacin—Pain—Memantine—Alzheimer's disease	0.000425	0.00228	CcSEcCtD
Darifenacin—Trospium—CYP2D6—Alzheimer's disease	0.000421	0.205	CrCbGaD
Darifenacin—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00042	0.00226	CcSEcCtD
Darifenacin—Nausea—Galantamine—Alzheimer's disease	0.00042	0.00226	CcSEcCtD
Darifenacin—CHRM3—central nervous system—Alzheimer's disease	0.000419	0.026	CbGeAlD
Darifenacin—Constipation—Rivastigmine—Alzheimer's disease	0.000416	0.00223	CcSEcCtD
Darifenacin—Pain—Rivastigmine—Alzheimer's disease	0.000416	0.00223	CcSEcCtD
Darifenacin—Feeling abnormal—Memantine—Alzheimer's disease	0.00041	0.0022	CcSEcCtD
Darifenacin—CHRM2—brain—Alzheimer's disease	0.000408	0.0253	CbGeAlD
Darifenacin—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000406	0.00218	CcSEcCtD
Darifenacin—Hypersensitivity—Donepezil—Alzheimer's disease	0.000403	0.00217	CcSEcCtD
Darifenacin—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000401	0.00215	CcSEcCtD
Darifenacin—CYP2D6—telencephalon—Alzheimer's disease	0.000398	0.0247	CbGeAlD
Darifenacin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000398	0.00214	CcSEcCtD
Darifenacin—Abdominal pain—Memantine—Alzheimer's disease	0.000393	0.00211	CcSEcCtD
Darifenacin—Asthenia—Donepezil—Alzheimer's disease	0.000393	0.00211	CcSEcCtD
Darifenacin—Pruritus—Donepezil—Alzheimer's disease	0.000387	0.00208	CcSEcCtD
Darifenacin—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000384	0.00207	CcSEcCtD
Darifenacin—Diarrhoea—Donepezil—Alzheimer's disease	0.000375	0.00201	CcSEcCtD
Darifenacin—CHRM1—brain—Alzheimer's disease	0.000372	0.0231	CbGeAlD
Darifenacin—Hypersensitivity—Memantine—Alzheimer's disease	0.000366	0.00197	CcSEcCtD
Darifenacin—Dizziness—Donepezil—Alzheimer's disease	0.000362	0.00195	CcSEcCtD
Darifenacin—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000358	0.00193	CcSEcCtD
Darifenacin—Asthenia—Memantine—Alzheimer's disease	0.000357	0.00192	CcSEcCtD
Darifenacin—Pruritus—Memantine—Alzheimer's disease	0.000352	0.00189	CcSEcCtD
Darifenacin—Asthenia—Rivastigmine—Alzheimer's disease	0.000349	0.00188	CcSEcCtD
Darifenacin—Vomiting—Donepezil—Alzheimer's disease	0.000348	0.00187	CcSEcCtD
Darifenacin—Rash—Donepezil—Alzheimer's disease	0.000345	0.00186	CcSEcCtD
Darifenacin—Dermatitis—Donepezil—Alzheimer's disease	0.000345	0.00185	CcSEcCtD
Darifenacin—Pruritus—Rivastigmine—Alzheimer's disease	0.000344	0.00185	CcSEcCtD
Darifenacin—Headache—Donepezil—Alzheimer's disease	0.000343	0.00184	CcSEcCtD
Darifenacin—Diarrhoea—Memantine—Alzheimer's disease	0.00034	0.00183	CcSEcCtD
Darifenacin—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000333	0.00179	CcSEcCtD
Darifenacin—CHRM3—brain—Alzheimer's disease	0.000333	0.0206	CbGeAlD
Darifenacin—Dizziness—Memantine—Alzheimer's disease	0.000329	0.00177	CcSEcCtD
Darifenacin—Nausea—Donepezil—Alzheimer's disease	0.000325	0.00175	CcSEcCtD
Darifenacin—Dizziness—Rivastigmine—Alzheimer's disease	0.000322	0.00173	CcSEcCtD
Darifenacin—Vomiting—Memantine—Alzheimer's disease	0.000316	0.0017	CcSEcCtD
Darifenacin—Rash—Memantine—Alzheimer's disease	0.000313	0.00168	CcSEcCtD
Darifenacin—Dermatitis—Memantine—Alzheimer's disease	0.000313	0.00168	CcSEcCtD
Darifenacin—Headache—Memantine—Alzheimer's disease	0.000311	0.00167	CcSEcCtD
Darifenacin—Vomiting—Rivastigmine—Alzheimer's disease	0.000309	0.00166	CcSEcCtD
Darifenacin—Rash—Rivastigmine—Alzheimer's disease	0.000307	0.00165	CcSEcCtD
Darifenacin—Dermatitis—Rivastigmine—Alzheimer's disease	0.000306	0.00165	CcSEcCtD
Darifenacin—Headache—Rivastigmine—Alzheimer's disease	0.000305	0.00164	CcSEcCtD
Darifenacin—Fexofenadine—CYP2D6—Alzheimer's disease	0.000298	0.145	CrCbGaD
Darifenacin—Nausea—Memantine—Alzheimer's disease	0.000295	0.00159	CcSEcCtD
Darifenacin—Nausea—Rivastigmine—Alzheimer's disease	0.000289	0.00155	CcSEcCtD
Darifenacin—CYP3A4—nervous system—Alzheimer's disease	0.000239	0.0148	CbGeAlD
Darifenacin—CYP2D6—nervous system—Alzheimer's disease	0.000235	0.0146	CbGeAlD
Darifenacin—CYP3A4—central nervous system—Alzheimer's disease	0.00023	0.0143	CbGeAlD
Darifenacin—Clotrimazole—CYP2D6—Alzheimer's disease	0.00023	0.112	CrCbGaD
Darifenacin—CYP2D6—central nervous system—Alzheimer's disease	0.000226	0.0141	CbGeAlD
Darifenacin—CYP2D6—cerebellum—Alzheimer's disease	0.000221	0.0137	CbGeAlD
Darifenacin—Loperamide—CYP2D6—Alzheimer's disease	0.000189	0.0922	CrCbGaD
Darifenacin—CYP2D6—brain—Alzheimer's disease	0.00018	0.0112	CbGeAlD
Darifenacin—Methadone—CYP2D6—Alzheimer's disease	0.000135	0.0657	CrCbGaD
Darifenacin—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	1.32e-05	0.000297	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	1.31e-05	0.000295	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	1.31e-05	0.000294	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PRKCG—Alzheimer's disease	1.3e-05	0.000292	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SST—Alzheimer's disease	1.29e-05	0.00029	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	1.29e-05	0.00029	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	1.29e-05	0.00029	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	1.28e-05	0.000289	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	1.28e-05	0.000289	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SST—Alzheimer's disease	1.28e-05	0.000289	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	1.28e-05	0.000289	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—LPL—Alzheimer's disease	1.28e-05	0.000288	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	1.28e-05	0.000288	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	1.28e-05	0.000287	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	1.27e-05	0.000286	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	1.27e-05	0.000286	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SST—Alzheimer's disease	1.27e-05	0.000286	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	1.27e-05	0.000286	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.27e-05	0.000286	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MEF2C—Alzheimer's disease	1.27e-05	0.000285	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	1.27e-05	0.000285	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NGF—Alzheimer's disease	1.27e-05	0.000285	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	1.26e-05	0.000284	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APP—Alzheimer's disease	1.26e-05	0.000282	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APP—Alzheimer's disease	1.25e-05	0.000282	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PRKCG—Alzheimer's disease	1.24e-05	0.00028	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APP—Alzheimer's disease	1.24e-05	0.000279	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCR5—Alzheimer's disease	1.23e-05	0.000277	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.22e-05	0.000275	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NGF—Alzheimer's disease	1.21e-05	0.000273	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	1.21e-05	0.000271	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HTR2A—Alzheimer's disease	1.21e-05	0.000271	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	1.2e-05	0.00027	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	1.19e-05	0.000268	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	1.19e-05	0.000267	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	1.18e-05	0.000266	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.18e-05	0.000266	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	1.18e-05	0.000265	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCR5—Alzheimer's disease	1.18e-05	0.000265	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—HMOX1—Alzheimer's disease	1.18e-05	0.000264	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	1.17e-05	0.000263	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HTR2A—Alzheimer's disease	1.15e-05	0.00026	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CALM1—Alzheimer's disease	1.12e-05	0.000253	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—APOE—Alzheimer's disease	1.12e-05	0.000252	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—LEP—Alzheimer's disease	1.12e-05	0.000252	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CAV1—Alzheimer's disease	1.11e-05	0.00025	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	1.11e-05	0.000249	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	1.1e-05	0.000248	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	1.1e-05	0.000247	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	1.1e-05	0.000246	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	1.09e-05	0.000246	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	1.08e-05	0.000244	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	1.08e-05	0.000243	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CALM1—Alzheimer's disease	1.08e-05	0.000242	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	1.08e-05	0.000242	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	1.08e-05	0.000242	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—LPL—Alzheimer's disease	1.07e-05	0.000242	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—LEP—Alzheimer's disease	1.07e-05	0.000241	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APOE—Alzheimer's disease	1.07e-05	0.000241	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	1.07e-05	0.000241	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ESR1—Alzheimer's disease	1.07e-05	0.000241	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	1.07e-05	0.00024	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CAV1—Alzheimer's disease	1.06e-05	0.000239	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	1.06e-05	0.000239	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—F2—Alzheimer's disease	1.06e-05	0.000238	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NOTCH1—Alzheimer's disease	1.03e-05	0.000233	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ACHE—Alzheimer's disease	1.03e-05	0.000231	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ESR1—Alzheimer's disease	1.02e-05	0.00023	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	1.02e-05	0.00023	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	1.02e-05	0.000229	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	1.02e-05	0.000228	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—F2—Alzheimer's disease	1.01e-05	0.000228	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	1.01e-05	0.000227	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NOTCH1—Alzheimer's disease	9.9e-06	0.000223	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	9.73e-06	0.000219	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GSK3B—Alzheimer's disease	9.71e-06	0.000218	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	9.69e-06	0.000218	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—MTHFR—Alzheimer's disease	9.68e-06	0.000218	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ENO1—Alzheimer's disease	9.63e-06	0.000217	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	9.63e-06	0.000217	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CREB1—Alzheimer's disease	9.63e-06	0.000217	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	9.6e-06	0.000216	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—INS—Alzheimer's disease	9.57e-06	0.000215	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCL2—Alzheimer's disease	9.42e-06	0.000212	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	9.4e-06	0.000211	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	9.37e-06	0.000211	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GSK3B—Alzheimer's disease	9.29e-06	0.000209	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	9.28e-06	0.000209	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IGF1—Alzheimer's disease	9.26e-06	0.000208	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CREB1—Alzheimer's disease	9.22e-06	0.000207	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—INS—Alzheimer's disease	9.17e-06	0.000206	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CALM1—Alzheimer's disease	9.04e-06	0.000203	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL2—Alzheimer's disease	9.02e-06	0.000203	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	9.02e-06	0.000203	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—APOE—Alzheimer's disease	9.01e-06	0.000203	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	8.99e-06	0.000202	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—BCHE—Alzheimer's disease	8.95e-06	0.000201	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	8.93e-06	0.000201	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CAV1—Alzheimer's disease	8.93e-06	0.000201	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	8.91e-06	0.0002	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	8.9e-06	0.0002	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IGF1—Alzheimer's disease	8.87e-06	0.000199	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	8.82e-06	0.000198	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	8.77e-06	0.000197	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	8.74e-06	0.000197	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—TPI1—Alzheimer's disease	8.67e-06	0.000195	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CHAT—Alzheimer's disease	8.67e-06	0.000195	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	8.65e-06	0.000195	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	8.54e-06	0.000192	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	8.51e-06	0.000191	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	8.45e-06	0.00019	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	8.43e-06	0.00019	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NOS3—Alzheimer's disease	8.4e-06	0.000189	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MAOB—Alzheimer's disease	8.31e-06	0.000187	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	8.31e-06	0.000187	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	8.28e-06	0.000186	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	8.2e-06	0.000184	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	8.19e-06	0.000184	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	8.13e-06	0.000183	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	8.1e-06	0.000182	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NOS3—Alzheimer's disease	8.04e-06	0.000181	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	8.02e-06	0.00018	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	8e-06	0.00018	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PPARG—Alzheimer's disease	7.85e-06	0.000176	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—A2M—Alzheimer's disease	7.72e-06	0.000174	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—INS—Alzheimer's disease	7.7e-06	0.000173	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	7.58e-06	0.000171	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	7.56e-06	0.00017	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	7.56e-06	0.00017	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	7.56e-06	0.00017	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	7.53e-06	0.000169	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	7.53e-06	0.000169	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	7.49e-06	0.000168	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	7.49e-06	0.000168	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	7.46e-06	0.000168	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	7.46e-06	0.000168	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	7.46e-06	0.000168	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	7.39e-06	0.000166	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	7.21e-06	0.000162	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—AKT1—Alzheimer's disease	7.19e-06	0.000162	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	7.19e-06	0.000162	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CASP3—Alzheimer's disease	7.13e-06	0.00016	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—F2—Alzheimer's disease	7.13e-06	0.00016	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	7.12e-06	0.00016	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—F2—Alzheimer's disease	7.1e-06	0.00016	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—Alzheimer's disease	7.08e-06	0.000159	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	7.06e-06	0.000159	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—F2—Alzheimer's disease	7.03e-06	0.000158	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	7.03e-06	0.000158	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	6.97e-06	0.000157	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	6.95e-06	0.000156	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	6.89e-06	0.000155	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.88e-06	0.000155	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CASP3—Alzheimer's disease	6.83e-06	0.000154	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—Alzheimer's disease	6.78e-06	0.000153	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—NOS3—Alzheimer's disease	6.75e-06	0.000152	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ACHE—Alzheimer's disease	6.72e-06	0.000151	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	6.64e-06	0.000149	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	6.55e-06	0.000147	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	6.54e-06	0.000147	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	6.53e-06	0.000147	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	6.52e-06	0.000147	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	6.49e-06	0.000146	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	6.47e-06	0.000146	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	6.46e-06	0.000145	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—INS—Alzheimer's disease	6.46e-06	0.000145	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—INS—Alzheimer's disease	6.44e-06	0.000145	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—LPL—Alzheimer's disease	6.43e-06	0.000145	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	6.41e-06	0.000144	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—INS—Alzheimer's disease	6.37e-06	0.000143	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	6.35e-06	0.000143	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	6.33e-06	0.000142	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ENO1—Alzheimer's disease	6.3e-06	0.000142	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	6.3e-06	0.000142	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	6.27e-06	0.000141	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	6.27e-06	0.000141	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	6.26e-06	0.000141	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	6.24e-06	0.00014	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	6.22e-06	0.00014	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	6.18e-06	0.000139	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—Alzheimer's disease	6.17e-06	0.000139	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	6.16e-06	0.000139	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	6.05e-06	0.000136	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.85e-06	0.000132	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	5.79e-06	0.00013	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	5.79e-06	0.00013	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	5.66e-06	0.000127	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	5.64e-06	0.000127	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	5.59e-06	0.000126	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	5.55e-06	0.000125	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.52e-06	0.000124	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CALM1—Alzheimer's disease	5.41e-06	0.000122	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOE—Alzheimer's disease	5.39e-06	0.000121	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.35e-06	0.00012	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CAV1—Alzheimer's disease	5.34e-06	0.00012	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	5.32e-06	0.00012	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.85e-06	0.000109	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	4.84e-06	0.000109	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	4.81e-06	0.000108	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	4.79e-06	0.000108	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.79e-06	0.000108	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	4.78e-06	0.000107	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	4.76e-06	0.000107	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	4.74e-06	0.000107	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	4.71e-06	0.000106	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARG—Alzheimer's disease	4.69e-06	0.000106	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.61e-06	0.000104	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—INS—Alzheimer's disease	4.6e-06	0.000103	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.59e-06	0.000103	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	4.57e-06	0.000103	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	4.42e-06	9.93e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	4.41e-06	9.91e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	4.4e-06	9.9e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	4.39e-06	9.88e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	4.38e-06	9.84e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	4.36e-06	9.81e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	4.35e-06	9.78e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.2e-06	9.45e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	4.18e-06	9.41e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	4.08e-06	9.17e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	4.07e-06	9.14e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—NOS3—Alzheimer's disease	4.04e-06	9.08e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	4.03e-06	9.05e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	4.01e-06	9.01e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	3.86e-06	8.68e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.78e-06	8.51e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	3.74e-06	8.42e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	3.73e-06	8.39e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	3.7e-06	8.31e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	3.7e-06	8.31e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.69e-06	8.3e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.53e-06	7.95e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.52e-06	7.92e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.49e-06	7.85e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—AKT1—Alzheimer's disease	3.1e-06	6.98e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	3.08e-06	6.93e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	3.07e-06	6.91e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.07e-06	6.9e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	3.04e-06	6.84e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—INS—Alzheimer's disease	3.01e-06	6.77e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	2.82e-06	6.34e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	2.81e-06	6.32e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	2.78e-06	6.26e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.64e-06	5.93e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	2.6e-06	5.85e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	2.59e-06	5.83e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	2.57e-06	5.78e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.41e-06	5.43e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.85e-06	4.17e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.21e-06	2.73e-05	CbGpPWpGaD
